Replying to @⁨themachinestops@lemmy.dbzer0.com⁩

How much is the cure/treatment for Parkinson’s worth? Or other intractable medical problems?

What about a device able to manipulate the containment field of a fusion reactor?

These are the reasons why everyone is buying the compute services - there are dozens of moonshot-grade problems that are suddenly possible to attempt. Many will fail, but whoever gets that one success will gain astronomical benefit.

en

Replying to @⁨CameronDev@programming.dev⁩

Generally speaking, yes, but standard LLMs now have their own built-in image recognition so we might not be too far off from LLMs being able to describe to the doctor what they should look at on an image that’s been flagged. Take a capable LLM of a few hundred billion parameters, train it on tons of medical images and such, and it might actually be helpful. Or it might not, no way to find out until tested.

Replying to @⁨Xaphanos@lemmy.world⁩

I’m aware, and I wish people were more clear about the difference, but its LLMs that are driving these insane buildouts, not the other disciplines. This article is clearly talking about the LLM “AI”, not bioinformatics or anything that may actually be fruitful.

The LLM companies like to claim they’ll solve cancer, but its all snake oil hedged on a mythical AGI popping up and fixing everything.

Replying to @⁨Xaphanos@lemmy.world⁩

Surely in the age of self-promoting narcissists we would hear about these break-throughs in all the media?.. Not just “it can potentially cure cancer if you give us another $tn”, the real results under review by relevant authorities/academics. Moreover, these breakthroughs do require a shitload of compute, but I do not see how a chatbot could be helpful with it. Other than, of course, stealing the preprinted work of some academic and claiming it their own, as recently with OpenAI Navier–Stokes equations conundrum. Can you imagine how many problems like that would already be solved if all these billions were spent on it, rather than chatbots drawing glossy pics?..

Replying to @⁨Bloodyhog@lemmy.world⁩

You may be missing my point. THEY aren’t being kept in the dark. YOU are. Anyone involved in the project signs an NDA. Then the relevant experts can’t talk about it.

This is big with legislators too. They are taken on tours under NDA. They see there is no water use, they listen to the noise levels, they see the new substation provided to the community. But they cannot tell the constituents those specifics. Only “it’s not like the news is claiming”.

And the news is not the customer. No one in the industry cares about bad press. Customers won’t stop buying. So the build out accelerates.

Replying to @⁨Xaphanos@lemmy.world⁩

AI has been mainstream for what, 4 years now?

if AI had such powerful results for developing novel solutions to problems such as medicine or material science, why have we not seen major improvements in those sectors?

the way AI is spoken about is that it’s “world impacting” and “sector disrupting”. the only disruption and impacts I’m seeing are in human rights violations, price gouging, privacy negation, and corruption.

if these are the results after only 4 years, I can only logically assume it will only get worse with more time and support.

Replying to @⁨GreenKnight23@lemmy.world⁩

Takes years to get new drugs to market. AI is speeding up drug discovery by predicting protein folding ridiculously fast, but there’s a lot of other work that needs to be done. Perhaps there will be models to speed up some of those processes too, but the real bottleneck is approvals and while AI might be used to speed up the paperwork part of it, I can’t think of any way it’ll be able to speed up actual trials. What I suspect will happen is we’ll get an even faster response time with the next global pandemic that requires a vaccine, and we’ll start getting more and more mRNA vaccines, including some for some types of cancers.

This paper details 9 processes in which AI is already helping or is predicted to be able to help in material development. Material development also takes time to get anything to market, for various reasons. But there’s a nonzero chance that the recent battery tech boom from China has been aided by AI. They just tested a very high density solid state cell not long ago.

PubMed Central (PMC)Computational biology and artificial intelligence in mRNA vaccine design for cancer immunotherapyMessenger RNA (mRNA) vaccines offer an adaptable and scalable platform for cancer immunotherapy, requiring optimal design to elicit a robust and targeted immune response. Recent advancements in bioinformatics and artificial intelligence (AI) have ...

Replying to @⁨boonhet@sopuli.xyz⁩

if it wasn’t maliciously designed it’s absurdly negligent. both of which are reason enough to not use AI at all.

wouldn’t it make more sense to streamline the existing processes first before creating a traffic jam of “potential” cures? where at least the models could be trained on existing cutting edge medical research instead of flying blind and developing novel treatments and cures.

the more I think about it the more is seems plausible that the actions AI implementation takes is malicious negligence. incompetence derived from a malicious intent to do harm on someone or something.

is this the disruption AI execs were talking about?